Clinical Skin Revenue and Competitors

Hackensack, NJ USA

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • Clinical Skin's estimated annual revenue is currently $16.7M per year.(i)
  • Clinical Skin's estimated revenue per employee is $201,000

Employee Data

  • Clinical Skin has 83 Employees.(i)
  • Clinical Skin grew their employee count by 54% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$5M25-11%N/AN/A
#2
$35.8M1788%N/AN/A
#3
$5.4M27-25%N/AN/A
#4
$4180M145161%$550MN/A
#5
$12.5M6215%N/AN/A
#6
$6.7M119-37%$199.6MN/A
#7
$9.4M477%N/AN/A
#8
$10.3M516%N/AN/A
#9
$106.3M52916%N/AN/A
#10
$15.5M7720%N/AN/A
Add Company

What Is Clinical Skin?

Clinical Skin is a professional-grade skincare and facial tool line developed to address the signs of skin aging and yield results without irritation. \n\nThe brand employs a pharmaceutical approach to beauty and delivers an efficacious, science-backed, clinically-validated and extensively researched rejuvenating collection. \n\nAt the root of all Clinical Skin formulas is a proprietary blend of specialty ingredients known as A.C.E. Technology™, a combination of broad-spectrum antioxidants, biomimetic ceramides and an anti-oxidative enzyme.\n\nThe product portfolio is built around a single hero product, The Polypeptide Firming Serum. Delivering immediate and long-term results, the serum was clinically tested in a 12-week double-blind study by an independent body to validate its efficacy and safety. The study found statistically significant improvement in the appearance of fine lines, wrinkles and firmness in as soon as four weeks of use and those results continued to increase over the course of the study. Clinical study data on file at Clinical Skin, LLC.

keywords:N/A

N/A

Total Funding

83

Number of Employees

$16.7M

Revenue (est)

54%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$11.9M854%$192.3M
#2
$13.1M87-22%N/A
#3
$12.6M8771%N/A
#4
$19.1M8716%N/A
#5
$28.7M8913%N/A